Quality Of Life On Elderly Patients With Low Grade Non-Hodgkin Lymphoma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age70+
SponsorFondazione Italiana Linfomi - ETS
About this trial
Aims of this study are to describe the variation of QoL (Quality of Life) during the clinical management of low-grade lymphoma in elderly subjects and to identify the most important factors at diagnosis and during treatment with an impact on QoL (Quality of Life).
Eligibility criteria
Qualifiers
Local histological diagnosis of indolent B cell non-Hodgkin lymphoma: follicular lymphoma, marginal zone lymphoma (nodal, MALT (Mucosa-Associated Lymphoid Tissue), splenic), lymphoplasmacytic lymphoma/ Waldenström macroglobulinemia)
Age ≥ 70 years
Patient candidates to receive treatment for lymphoma
Patient previously untreated for lymphoma
Disqualifiers
none
Trial design
Treatments tested in this trial
- Not listed
Trial groups
150 Participants
are grouped into 1 trial groupLocations
20S.C. Ematologia - A.O. SS. Antonio e Biagio e Cesare Arrigo15121, AlessandriaAlessandria, Italy
Clinica di Ematologia - A.O.U. Ospedali Riuniti60126, AnconaItaly, Italy
U.O.C. Ematologia - IRCCS Istituto Tumori Giovanni Paolo II70124, BariItaly, Italy
Ematologia - ASST Spedali Civili di Brescia25123, BresciaItaly, Italy
Sponsors and collaborators
Fondazione Italiana Linfomi - ETS
Lead sponsor
Source ClinicalTrials.gov